Litcius/Paper detail

The production and bioactivity of prodigiosin: quo vadis?

Shian‐Ren Lin, Yu‐Hsin Chen, Feng-Jen Tseng, Ching‐Feng Weng

2020Drug Discovery Today48 citationsDOIOpen Access PDF

Abstract

Prodigiosin (PG), a red tripyrrole pigment, belongs to a member of the prodiginine family and is normally secreted by various sources including Serratia marcescens and other Gram-negative bacteria. The studies of PG have received innovative devotion as a result of reported antimicrobial, larvicidal and anti-nematoid immunomodulation and antitumor properties, owing to its antibiotic and cytotoxic activities. This review provides a comprehensive summary of research undertaken toward the isolation and structural elucidation of the prodiginine family of natural products. Additionally, the current evidence-based understanding of the biological activities and medicinal potential of PG is employed to determine the efficacy, with some reports of information related to pharmacokinetics, pharmacodynamics and toxicology.

Topics & Concepts

ProdigiosinSerratia marcescensAntimicrobialBiologyAntibioticsPharmacologyMicrobiologyChemistryTraditional medicineComputational biologyMedicineBiochemistryEscherichia coliGeneMicrobial Metabolism and ApplicationsPharmacological Effects of Natural CompoundsMicrobial Natural Products and Biosynthesis
The production and bioactivity of prodigiosin: quo vadis? | Litcius